These results spotlight cannabis’s opportunity as a therapeutic selection for people with persistent agony conditions.Dronabinol is classed as a pregnancy Group C drug, because it hasn't exhibited teratogenic outcomes in animal designs at doses starting from 0.two to 5 situations the utmost suggested human dose. However, it is vital to note that